These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21421459)

  • 21. [Preclinical and clinical profile of zoledronic acid (Zometa) for hypercalcemia of malignancy].
    Tomoo T; Suzuki M
    Nihon Yakurigaku Zasshi; 2005 Nov; 126(5):353-7. PubMed ID: 16394581
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of Zoledronic Acid on Atrial Electrophysiological Parameters and Electrocardiographic Measurements.
    Tisdale JE; Allen MR; Overholser BR; Jaynes HA; Kovacs RJ
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):671-7. PubMed ID: 25684326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface.
    Li YF; Li XD; Bao CY; Chen QM; Zhang H; Hu J
    Osteoporos Int; 2013 Mar; 24(3):1063-71. PubMed ID: 23296744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts.
    Hirbe AC; Roelofs AJ; Floyd DH; Deng H; Becker SN; Lanigan LG; Apicelli AJ; Xu Z; Prior JL; Eagleton MC; Piwnica-Worms D; Rogers MJ; Weilbaecher K
    Bone; 2009 May; 44(5):908-16. PubMed ID: 19442620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effect of zoledronic acid on human vascular smooth muscle cells.
    Albadawi H; Haurani MJ; Oklu R; Trubiano JP; Laub PJ; Yoo HJ; Watkins MT
    J Surg Res; 2013 Jun; 182(2):339-46. PubMed ID: 23164362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zoledronic acid decreases bone formation without causing osteocyte death in mice.
    Huja SS; Fernandez SA; Phillips C; Li Y
    Arch Oral Biol; 2009 Sep; 54(9):851-6. PubMed ID: 19591974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer.
    James N; Pirrie S; Pope A; Barton D; Andronis L; Goranitis I; Collins S; McLaren D; O'Sullivan J; Parker C; Porfiri E; Staffurth J; Stanley A; Wylie J; Beesley S; Birtle A; Brown J; Chakraborti P; Russell M; Billingham L
    Health Technol Assess; 2016 Jul; 20(53):1-288. PubMed ID: 27434595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zoledronic acid - a multiplicity of anti-cancer action.
    Yuasa T; Kimura S; Ashihara E; Habuchi T; Maekawa T
    Curr Med Chem; 2007; 14(20):2126-35. PubMed ID: 17691952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches.
    Soki FN; Li X; Berry J; Koh A; Sinder BP; Qian X; Kozloff KM; Taichman RS; McCauley LK
    J Cell Biochem; 2013 Jan; 114(1):67-78. PubMed ID: 22833499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can we consider zoledronic acid a new antitumor agent? Recent evidence in clinical setting.
    Santini D; Virzi V; Fratto ME; Bertoldo F; Sabbatini R; Berardi R; Calipari N; Ottaviani D; Ibrahim T
    Curr Cancer Drug Targets; 2010 Feb; 10(1):46-54. PubMed ID: 20088792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents.
    Koto K; Murata H; Kimura S; Horie N; Matsui T; Nishigaki Y; Ryu K; Sakabe T; Itoi M; Ashihara E; Maekawa T; Fushiki S; Kubo T
    Oncol Rep; 2010 Jul; 24(1):233-9. PubMed ID: 20514467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zoledronic acid induces apoptosis via stimulating the expressions of ERN1, TLR2, and IRF5 genes in glioma cells.
    Biray Avci C; Kurt CC; Tepedelen BE; Ozalp O; Goker B; Mutlu Z; Dodurga Y; Elmas L; Gunduz C
    Tumour Biol; 2016 May; 37(5):6673-9. PubMed ID: 26646564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Effects of Systemic Zoledronic Acid Application on Bone Maturation in the Consolidation Period in Distraction Osteogenesis.
    Akbulut Y; Gul M; Dundar S; Ozcan EC; Ozercan IH; Bozoglan A; Karasu N; Acikan I; Bingül MB
    J Craniofac Surg; 2021 Nov-Dec 01; 32(8):2901-2905. PubMed ID: 33935139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisphosphonates as anticancer therapy for early breast cancer.
    Mahtani R; Jahanzeb M
    Clin Breast Cancer; 2010 Oct; 10(5):359-66. PubMed ID: 20920980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro.
    Räikkönen J; Crockett JC; Rogers MJ; Mönkkönen H; Auriola S; Mönkkönen J
    Br J Pharmacol; 2009 Jun; 157(3):427-35. PubMed ID: 19371349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antitumor activity of zoledronic acid].
    Tamási L
    Magy Onkol; 2009 Sep; 53(3):269-71. PubMed ID: 19793692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-tumour activity of zoledronic acid.
    Clézardin P
    Cancer Treat Rev; 2005; 31 Suppl 3():1-8. PubMed ID: 16225995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zoledronic acid: a review of its use in the management of bone metastases and hypercalcaemia of malignancy.
    Wellington K; Goa KL
    Drugs; 2003; 63(4):417-37. PubMed ID: 12558465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of BK(Ca) channels in zoledronic acid-induced apoptosis of MDA-MB-231 breast cancer cells.
    Ma YG; Liu WC; Dong S; Du C; Wang XJ; Li JS; Xie XP; Wu L; Ma DC; Yu ZB; Xie MJ
    PLoS One; 2012; 7(5):e37451. PubMed ID: 22655048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of biologic versus bisphosphonate inhibition of wear debris-induced osteolysis assessed by longitudinal micro-CT.
    Tsutsumi R; Hock C; Bechtold CD; Proulx ST; Bukata SV; Ito H; Awad HA; Nakamura T; O'Keefe RJ; Schwarz EM
    J Orthop Res; 2008 Oct; 26(10):1340-6. PubMed ID: 18404739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.